Table 3.
Number of patients with a prescription for intermediate and long-acting insulins
| Type of insulin | All patients, n (%) (n= 7757) | Insulin-naive patients, n (%) (n= 1159) |
|---|---|---|
| Newer insulins | 1983 (25.6) | 282 (24.3) |
| Glargine 300 U/ml | 895 (11.5) | 120 (10.4) |
| Degludec | 1088 (14.0) | 162 (14.0) |
|
| ||
| Other insulins | 5774 (74.4) | 877 (75.7) |
| NPH-insulin | 1330 (17.1) | 303 (26.1) |
| Glargine 100 U/ml | 3516 (45.3) | 501 (43.2) |
| Detemir | 928 (12.0) | 73 (6.3) |